Evidence map›Paper›PMID 25635707›Full record

ArticleNature communications2015

Endothelial destabilization by angiopoietin-2 via integrin β1 activation.

Laura Hakanpaa, Tuomas Sipila, Veli-Matti Leppanen, Prson Gautam, Harri Nurmi, Guillaume Jacquemet, Lauri Eklund, Johanna Ivaska, Kari Alitalo, Pipsa Saharinen

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 177 papers.

0numbers the graph read from it
0cells of the map it votes in
177citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

177 citing papers in PubMed, 269 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Beyond the infusion: nursing at the vanguard of cytokine release syndrome rescue in CAR-T cell therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  13. Article
  14. Article
  15. Molecular stress and neurovascular injury in the diabetic retina.The Journal of clinical investigation · 2026
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

117 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Laura HakanpaaWihuri Research Institute and Research Programs Unit, Translational Cancer Biology Program and Department of Virology, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, PO Box 63, Helsinki FI-00014, Finland.
Tuomas SipilaWihuri Research Institute and Research Programs Unit, Translational Cancer Biology Program and Department of Virology, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, PO Box 63, Helsinki FI-00014, Finland.
Veli-Matti LeppanenWihuri Research Institute and Research Programs Unit, Translational Cancer Biology, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, PO Box 63, Helsinki FI-00014, Finland.
Prson GautamWihuri Research Institute and Research Programs Unit, Translational Cancer Biology Program and Department of Virology, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, PO Box 63, Helsinki FI-00014, Finland.
Harri NurmiWihuri Research Institute and Research Programs Unit, Translational Cancer Biology, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, PO Box 63, Helsinki FI-00014, Finland.
Guillaume JacquemetTurku Centre for Biotechnology, University of Turku and VTT, Tykistökatu 6 A, Turku FI-20520, Finland.
Lauri EklundFaculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, PO Box 5400, Biocenter Oulu FI-90014, Finland.
Johanna IvaskaTurku Centre for Biotechnology, University of Turku and VTT, Tykistökatu 6 A, Turku FI-20520, Finland.
Kari AlitaloWihuri Research Institute and Research Programs Unit, Translational Cancer Biology, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, PO Box 63, Helsinki FI-00014, Finland.
Pipsa SaharinenWihuri Research Institute and Research Programs Unit, Translational Cancer Biology Program and Department of Virology, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, PO Box 63, Helsinki FI-00014, Finland.
Wihuri Research Institute · FITurku Centre for Biotechnology · FIUniversity of Oulu · FIUniversity of Turku · FI

Funding

European Research Council 268804European Research Council 615258Worldwide Cancer Research 12-0181
6 · The paper itself

Abstract

Angiopoietins regulate vascular homeostasis via the endothelial Tie receptor tyrosine kinases. Angiopoietin-1 (Ang1) supports endothelial stabilization via Tie2 activation. Angiopoietin-2 (Ang2) functions as a context-dependent Tie2 agonist/antagonist promoting pathological angiogenesis, vascular permeability and inflammation. Elucidating Ang2-dependent mechanisms of vascular destablization is critical for rational design of angiopoietin antagonists that have demonstrated therapeutic efficacy in cancer trials. Here, we report that Ang2, but not Ang1, activates β1-integrin, leading to endothelial destablization. Autocrine Ang2 signalling upon Tie2 silencing, or in Ang2 transgenic mice, promotes β1-integrin-positive elongated matrix adhesions and actin stress fibres, regulating vascular endothelial-cadherin-containing cell-cell junctions. The Tie2-silenced monolayer integrity is rescued by β1-integrin, phosphoinositide-3 kinase or Rho kinase inhibition, and by re-expression of a membrane-bound Tie2 ectodomain. Furthermore, Tie2 silencing increases, whereas Ang2 blocking inhibits transendothelial tumour cell migration in vitro. These results establish Ang2-mediated β1-integrin activation as a promoter of endothelial destablization, explaining the controversial vascular functions of Ang1 and Ang2.

Indexed as

Angiopoietin-1Angiopoietin-2AnimalsCell LineEndothelial CellsFemaleHumansIntegrin beta1MaleMiceMice, TransgenicPregnancyReal-Time Polymerase Chain ReactionReceptor, TIE-2Angiopoietin-1Angiopoietin-2Integrin beta1Receptor, TIE-2

Identifiers

PMID25635707
PMCPMC4316742
OpenAlexW2077884715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.